★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
Zimmer Biomet Holdings, Inc. (ZBH) Moat Analysis
Zimmer Biomet Holdings, Inc.
ZBH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Zimmer Biomet Holdings, Inc. is a Delaware orthopedic-device manufacturer whose ordinary shares trade primarily on the NYSE and secondarily on SIX; this is not an ADR structure. At July 30, 2026, exactly 190,737,689 common shares were outstanding. Q2 net sales were $2,177.0M: Knees contributed 38.1%, S.E.T. 26.9%, Hips 25.8%, and Technology & Data/Bone Cement/Surgical 9.2%. The defensible mechanisms are moderate procedure-specific familiarity and case-readiness support in knees and hips: entrenched clinical practice, product-specific training, consigned inventory, instruments, and field representatives create switching friction, but Stryker, J&J and Smith+Nephew maintain comparable systems and hospital standardization remains powerful. The service and workflow mechanisms are scored separately but conservatively to avoid treating the same incumbent footprint as two strong moats.
Primary segment
Knees
Market structure
Oligopoly
Market share
30.1% (reported)
HHI: —
Coverage
4 segments · 5 tags
Updated 2026-08-23
Segments
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Revenue
38.1%
Structure
Oligopoly
Pricing
weak
Share
30.1% (reported)
Peers
Hips
Hip reconstruction implants (primary and revision) plus associated instruments and orthopedic robotics/navigation
Revenue
25.8%
Structure
Oligopoly
Pricing
weak
Share
23.5% (reported)
Peers
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Sports medicine, extremities, trauma, biologics and CMFT orthopedic devices
Revenue
26.9%
Structure
Competitive
Pricing
weak
Share
—
Peers
Technology & Data, Bone Cement and Surgical
Orthopedic surgical robotics and navigation, digital care pathways/analytics, bone cement, and surgical instruments
Revenue
9.2%
Structure
Oligopoly
Pricing
weak
Share
—
Peers
Moat Claims
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Revenue share uses Q2 2026 product-category sales of $828.9M divided by $2,177.0M total. Product categories are economic sales groups rather than the company's geographic reportable segments, and product-level operating profit is not disclosed.
Design In Qualification
Demand
Design In Qualification
Strength
Durability
Confidence
Evidence
Knee systems require product-specific technique, instruments, training, and OR familiarity. The filing identifies entrenched clinical practice as an adoption barrier, supporting moderate qualification friction, but surgeons can retrain and large health systems can standardize vendors.
Design In Qualification moat: definition, examples, and stocks
Erosion risks
- Hospital standardization reduces surgeon choice
- New implant designs narrow differentiation
- Shift of volume to price-sensitive ambulatory surgery centers
Leading indicators
- Knee share trend vs SYK/JNJ/SNN
- Pricing realization (net price/mix)
- Adoption rates of new knee platforms and robotics-assisted procedures
Counterarguments
- Surgeons can switch with retraining; competitors also run extensive education programs
- Hospitals can force standardization via tenders and bundled purchasing
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Consignment-heavy inventory and local clinical support improve case readiness and responsiveness. Replicating coverage is costly for a small entrant, but the other major orthopedic vendors operate comparable field and consignment models, limiting differentiation.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor/channel disruption
- ERP/logistics execution issues
- Hospital consolidation reduces the value of local density
Leading indicators
- Backorder/fill-rate metrics
- Rep productivity and churn
- Customer complaint / service levels
Counterarguments
- Large competitors have comparable field organizations and consignment models
- Health systems may centralize inventory and reduce vendor footprint
Hips
Hip reconstruction implants (primary and revision) plus associated instruments and orthopedic robotics/navigation
Revenue share uses Q2 2026 product-category sales of $562.7M divided by $2,177.0M total. Product-level operating profit is not disclosed.
Design In Qualification
Demand
Design In Qualification
Strength
Durability
Confidence
Evidence
Hip systems are embedded in procedure-specific technique and instrument workflows, creating moderate retraining and qualification friction. This is not a hard lock-in: competitors offer comparable implant families and health systems can consolidate suppliers.
Design In Qualification moat: definition, examples, and stocks
Erosion risks
- Commoditization of stems/cups
- Purchaser-driven standardization and tendering
Leading indicators
- Hip share trend vs SYK/JNJ/SNN
- Revision mix and outcomes data publications
Counterarguments
- Competitors offer comparable implant platforms and education programs
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Local field coverage and consigned inventory support case readiness and responsiveness, but no category-specific service retention, response-time, or margin evidence establishes a strong advantage over incumbent peers.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor instability in certain regions
- Execution issues that reduce service levels
Leading indicators
- Order fill rates and backorders
- Regional growth vs market
Counterarguments
- Incumbent peers also operate large field organizations
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Sports medicine, extremities, trauma, biologics and CMFT orthopedic devices
Revenue share uses Q2 2026 product-category sales of $586.0M divided by $2,177.0M total. Paragon 28 contributed 2.8 percentage points to Q2 S.E.T. growth; acquisition contribution is not treated as moat evidence.
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Field support and medical education aid case coverage across procedure types, but category breadth, acquisitions, and salesforce scale do not prove a durable advantage over equally capable orthopedic competitors.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor turnover in smaller markets
- Margin pressure reduces ability to fund field headcount
Leading indicators
- Salesforce productivity
- Service-level metrics (fill rates, instrument availability)
Counterarguments
- Peers also have sizable field teams; differentiation depends on execution
Technology & Data, Bone Cement and Surgical
Orthopedic surgical robotics and navigation, digital care pathways/analytics, bone cement, and surgical instruments
Revenue share uses Q2 2026 product-category sales of $199.4M divided by $2,177.0M total. Sales grew 21.1%, primarily from ROSA Robot and bone cement, but growth, an installed platform, and product breadth do not establish switching costs or proprietary lock-in without adoption, utilization, retention, or attach evidence.
Evidence
may not be accepted quickly or at all ... because of ... entrenched patterns of clinical practice
Directly identifies established clinical workflows as a barrier to adoption of competing or new systems.
Consignment sales represented approximately 85 percent of our net sales in 2025.
Consignment plus local inventory/rep coverage increases service levels and raises the operational cost of switching vendors.
Zimmer Biomet led... the knee... market with 30.1%... share...
Directly states 2023 worldwide knee implant share for Zimmer Biomet.
Zimmer Biomet led... the... hip market with... 23.5%... share...
Directly states 2023 worldwide hip implant share for Zimmer Biomet.
We utilize a network of sales associates...
Supports the existence of a scalable service/sales footprint relevant to procedure-driven categories.
Risks & Indicators
Erosion risks
- Hospital standardization reduces surgeon choice
- New implant designs narrow differentiation
- Shift of volume to price-sensitive ambulatory surgery centers
- Distributor/channel disruption
- ERP/logistics execution issues
- Hospital consolidation reduces the value of local density
Leading indicators
- Knee share trend vs SYK/JNJ/SNN
- Pricing realization (net price/mix)
- Adoption rates of new knee platforms and robotics-assisted procedures
- Backorder/fill-rate metrics
- Rep productivity and churn
- Customer complaint / service levels
Research ZBH elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.